A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Clinical trial NCT07023731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07023731
- Sponsor
- Arvinas Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2027-11-30
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.